QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ubbink, J. B. Articles by Becker, P. J. Search for Related Content PubMed PubMed Citation Articles by Ubbink, J. B. Articles by Becker, P. J.

Relationship Between Vitamin B-6 Status and Elevated Pyridoxal Kinase Levels Induced by Theophylline Therapy in Humans¹

Department of Chemical Pathology, University of Pretoria, Pretoria 0001, South Africa

Theophylline administration to seven healthy male volunteers resulted in a rapid and significant decline in both plasma and erythrocyte pyridoxal-5'-phosphate levels. Total erythrocyte pyridoxal kinase levels increased during 15 wk of theophylline treatment from a mean initial activity of 19.23 ± 5.03 (mean ± SD) to 62.64 ± 11.59 nmol pyridoxal-5'-phosphate formed/(g hemoglobin·h). Although plasma pyridoxal levels remained normal, the threefold increase in total erythrocyte pyridoxal kinase activity levels did not normalize plasma and erythrocyte pyridoxal-5'-phosphate levels. Pyridoxal-5'-phosphate hydrolysis was not affected by theophylline therapy. Increased pyridoxal oxidation was confirmed by elevated urinary 4-pyridoxic acid excretion after 15 wk of theophylline treatment. Mean erythrocyte alanine aminotransferase activity declined by 70%, and aspartate aminotransferase activity declined by 50%, indicating that decreased availability of pyridoxal-5'-phosphate can have widespread metabolic consequences. We conclude that the effect of theophylline on vitamin B-6 metabolism is not transitory and cannot be overcome by elevated intracellular levels of pyridoxal kinase. However, pyridoxine supplementation (10 mg/d for 1 wk) normalized indices of vitamin B-6 status and reversed the downward trend in both alanine aminotransferase and aspartate aminotransferase activity levels.

KEY WORDS: • theophylline • vitamin B-6 • pyridoxal kinase • humans

¹ Financial support from Vesta Medicines (Pty.) Ltd. and the South African Medical Research Council is gratefully acknowledged.

² Institute for Biostatistics, South African Medical Research Council, Pretoria, South Africa.

Manuscript received 29 January 1990. Revision accepted 14 May 1990.

This article has been cited by other articles:

				F. N. Musayev, M. L. Di Salvo, M. A. Saavedra, R. Contestabile, M. S. Ghatge, A. Haynes, V. Schirch, and M. K. Safo Molecular Basis of Reduced Pyridoxine 5'-Phosphate Oxidase Catalytic Activity in Neonatal Epileptic Encephalopathy Disorder J. Biol. Chem., November 6, 2009; 284(45): 30949 - 30956. [Abstract] [Full Text] [PDF]